|
Volumn 1, Issue 4, 2007, Pages 353-355
|
Chemotherapy and Cancer Stem Cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA CATENIN;
CD133 ANTIGEN;
CYTOTOXIC AGENT;
FLUOROURACIL;
INTERLEUKIN 4;
INTERLEUKIN 4 ANTIBODY;
INTERLEUKIN 4 RECEPTOR;
LIGAND;
OXALIPLATIN;
WNT PROTEIN;
ADVANCED CANCER;
CANCER CHEMOTHERAPY;
CANCER STEM CELL;
COLON CANCER;
DIGESTIVE SYSTEM CANCER;
DRUG SYNTHESIS;
GLIOBLASTOMA;
HUMAN;
LEUKEMIA;
MALIGNANT NEOPLASTIC DISEASE;
MICROSATELLITE INSTABILITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN TARGETING;
SHORT SURVEY;
SOLID TUMOR;
TESTIS CANCER;
TREATMENT FAILURE;
XENOTRANSPLANTATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DEATH;
COLONIC NEOPLASMS;
FLUOROURACIL;
HUMANS;
INTERLEUKIN-4;
MICE;
NEOPLASTIC STEM CELLS;
ORGANOPLATINUM COMPOUNDS;
RECEPTORS, INTERLEUKIN-4;
|
EID: 34848899578
PISSN: 19345909
EISSN: None
Source Type: Journal
DOI: 10.1016/j.stem.2007.09.011 Document Type: Short Survey |
Times cited : (130)
|
References (10)
|